Kim Kelderman

Insider Reports History

Location
614 Mckinley Place Ne, Minneapolis, MN
Signature
/s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kim Kelderman:

Insider Reports Filed by Kim Kelderman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TECH BIO-TECHNE Corp Jan 27, 2025 4 -$530K 4 Jan 29, 2025 Chief Executive Officer, Director
TECH BIO-TECHNE Corp Nov 1, 2024 1 -$183K 4 Nov 5, 2024 Chief Executive Officer, Director
TECH BIO-TECHNE Corp Aug 29, 2024 2 $99.9K 4 Sep 3, 2024 Chief Executive Officer, Director
TECH BIO-TECHNE Corp Aug 15, 2024 3 $0 4 Aug 19, 2024 Chief Executive Officer, Director
TECH BIO-TECHNE Corp Jul 31, 2024 3 -$249K 4 Aug 2, 2024 Chief Executive Officer, Director
TECH BIO-TECHNE Corp Nov 1, 2023 3 $0 4 Feb 5, 2024 Chief Operating Officer
TECH BIO-TECHNE Corp Nov 1, 2023 2 $0 4 Nov 3, 2023 Chief Operating Officer
TECH BIO-TECHNE Corp Aug 24, 2023 2 $100K 4 Aug 28, 2023 Pres. Diagnostics & Genom
TECH BIO-TECHNE Corp Aug 15, 2023 2 $0 4/A Dec 14, 2023 Pres. Diagnostics & Genom
TECH BIO-TECHNE Corp Aug 5, 2023 3 -$340K 4 Aug 8, 2023 Pres. Diagnostics & Genom
TECH BIO-TECHNE Corp Aug 23, 2022 2 $100K 4 Aug 25, 2022 Pres. Diagnostics & Genom
TECH BIO-TECHNE Corp Aug 15, 2022 3 $0 4 Aug 17, 2022 PRES. DIAGNOSTICS & GENOM
TECH BIO-TECHNE Corp Aug 7, 2022 3 -$465K 4 Aug 9, 2022 Pres. Diagnostics & Genom
TECH BIO-TECHNE Corp Feb 8, 2022 2 $300K 4 Feb 10, 2022 Pres. Diagnostics & Genom
TECH BIO-TECHNE Corp Nov 19, 2021 4 -$177K 4 Nov 23, 2021 Pres. Diagnostics & Genom
TECH BIO-TECHNE Corp Sep 22, 2021 1 -$435K 4 Sep 24, 2021 Pres. Diagnostics & Genom
TECH BIO-TECHNE Corp Aug 6, 2021 6 -$419K 4 Aug 10, 2021 Pres. Diagnostics & Genom
TECH BIO-TECHNE Corp Jun 9, 2021 1 -$351K 4 Jun 11, 2021 Pres. Diagnostics & Genom
TECH BIO-TECHNE Corp May 25, 2021 1 -$358K 4 May 27, 2021 Pres. Diagnostics & Genom